fda warns against compounded semaglutide issues warning about some versions of for diabetes, weight loss Compounded Semaglutide & Tirzepatide 2025:

Many reports showed that GLP-1 effects involve neural modulation and peripheral effects, which increase satiety, resting energy expenditure and lower plasma concentrations of free fatty acids [20]-[22]

The researchers also discovered that GLP-1 activated a signalling pathway in skin cells called MAPK/ERK, which is known to be involved in cell growth and division

Liraglutide and semaglutide are glucagon-like peptide-1 (GLP-1) receptor agonists that mimic a hormone that helps regulate blood sugar levels

Spending on GLP-1s has grown dramatically

Hundreds have answered the call so far, but the more stories we can share, the stronger our voice becomes